layer. The remainder of the excluded fractions were pooled (I 8.0 mL) and applied to a 3.0-mL column of DEAE-Sephacel equilibrated with the same solvent used for elution on Sephadex G-50. After the sample was applied and washed with 10 mL of solvent, a continuous 0.1 to 0.7 mol/L NaCI gradient was applied in the same solvent using a total of 60 mL. Fractions of 0.9 mL were collected at a flow rate of approximately 3.6 mL/h, and aliquots were counted for radioactivity.
For both medium and cell layer, a major 3H-labeled peak (A) and two 35S-babeled peaks (B and C) were identified.
Enzymatic and chemical treatment
An aliquot of each of the labeled peaks (A, B, and C) was dialyzed against distilled water, lyophilized, and subjected to one of the following treatments:
For personal use only. The extent of digestion was assessed by separating labeled digestion products from undigested material using Sephadex G-50 columns (0.7 x 30 cm) with 0.1 mol/L ammonium acetate in 20% ethanol as the eluting buffer.
Isopycnic
CsCl centrifugation.
A 300-tL aliquot of peak C was added to a 4 mol/L GuHCI solution (-4.0 mL), and the mixture was brought to an initial starting density of I .46 g/mL by adding solid CsCI (0.5 g/g).22 Dissociative density gradients were formed by centrifuging at 37,000 rpm at 10 #{176}C for 65 hours in an SW 50.1 rotor (Beckman Instruments, Inc. Fullerton, Calif). Gradients were divided into four equal fractions (Dl, D2, D3, D4) using a Beckman tube slicer, and an aliquot from each fraction was counted for radioactivity.
Molecular sieve chromatography.
For both medium and cell layer, portions of the major "S-labeled peak (peak C, see Fig 2) were concentrated first by diluting pooled fractions (-20 ml) with an equal volume of 8 mol/L urea buffer that did not contain NaCl to reduce NaCI concentration.
This mixture was then reapplied to a DEAE-Sephaceb column (bed volume, 0.6 mL). After sample application, the column was extracted with a small volume (0.6 to 0.8 mL) of 4 mol/L GuHCI buffer containing 0.5% Triton X-I00.27 Recovery for the concentration step was between 80% and 90%. The concentrated sample was applied to a preparative Sepharose CL-4B column (0.9 cm x 58 cm) and eluted with 4 mol/L GuHCI, For ,:
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